Location: Home
  • search
  • go
  • Relate News
  • 5/29/2023NHC and SATCM Issue the Action Plan for Comprehensively Elevating Medi...
  • 5/29/2023IQVIA: Chinese Hospital Drug Market Up 1.8% in Q1/2023
  • 5/29/2023A Share-Listed Chinese MedPharm Cos Report Performance in 2022 with Ov...
  • 5/29/2023Review of Leading Listed Chinese Pharma Cos by R&D Spending in 2022
  • 5/29/2023SAMR Fines Two Chinese Drug Ingredient Suppliers for Monopolistic Beha...
  • 5/26/2023NHC Publicizes the List of Pediatric Drugs Encouraged for R&D and Regi...
  • 5/26/2023Sanofi Launches Innovative New Diabetes Drug Soliqua in China
  • 5/26/2023Moderna Looks to Build China Business with a Newly Established $100M L...
  • 5/26/2023Recent Executive Moves
  • 5/26/2023Drug R&D and Product Registration News Digest May 2023 (3)
  • 5/26/2023China's Middle Class – Growth, Policy, and Consumption (China Briefin...
  • 5/26/2023China's Souped-up Data Privacy Laws Deter Researchers (Nature)
  • 5/25/2023China Issues A Set of Guidelines for Basic Elderly Care System by 2025
  • 5/25/2023Korea's IVI Signs MOU with Nankai University for Joint Vaccine Researc...
  • 5/24/2023NMPA Solicits Comments on New Document on Strengthening Regulation of ...
  • 5/24/2023CDE Solicits Comments on the Draft Announcement for Generic Research o...
  • 5/24/2023Yimi Research: 2023 Survey on Effective Communication Channels with Ch...
  • 5/23/2023NMPA and NHC Issue Notice to Strengthen Regulation of Tramadol and Oth...
  • 5/23/2023Select Chinese Pharma Stock Surge as Covid-19 Rebounds in China
  • 5/23/2023Clover Expands Sales Network for Upcoming Quadrivalent Seasonal Influ...
  • 5/22/2023PhIIC: Chinese Retail Pharmacy Sales Continued to Decline in Q1/2023
  • 5/22/2023Pharnexcloud: Chinese Hospital Drug Market Down Slightly in 2022 Under...
  • 5/22/2023SMEI: Chinese Terminal Drug Market Growth Slowed to 1.1% in 2022 (Upda...
  • 5/22/2023PhIIC Reviews Import Oncology and Anti-infective Drug Approvals in 202...
  • 5/22/2023Doctor-influencers Ae Going Viral in China, Provoking Authorities (ROW...
  • 5/19/2023CStone Breaks Up With Drugs Partner As U.S. Rollout Stalls (Bamboo Wor...
  • 5/19/2023April Fundraising Rebounds with $315M Capital Injection to Hasten Biop...
  • 5/19/2023An AstraZeneca Executive Said the Quiet Part about China Out Loud (Qua...
  • 5/19/2023EQRx Terminates Licensing Agreement with CStone for Sugemalimab and No...
  • 5/19/2023uBriGene Acquires Mustang Bio's Facility in Worcester MA
  • Page:102/775 Total number of articles:23243: [First][<<] [100] [101] [102] [103] [104] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group